
1X Technologies
Hardware sale ($20k one-time) or recurring subscription ($499/mo, both include required services) for the consumer NEO robot, with paid/permissioned remote-teleoperation 'Expert Mode' assistance; parallel B2B channel via a partnership to make up to 10,000 units available to EQT portfolio companies. Data-flywheel thesis: teleop sessions generate training data to raise autonomy over time.
The ~$10B Series C is a reported TARGET for an in-progress raise (up to $1B), not a confirmed closed valuation — the ~12x step-up over Series B rests on the NEO consumer-launch narrative and a sector-wide humanoid re-rating, not disclosed financials. An earlier Series A2 (~$23.5M, Mar 2023, incl. OpenAI / EQT Ventures / Tiger Global / Samsung NEXT) predates these points but its post-money was not disclosed, so it is omitted from the trail.
Earnings, margins, COGS & capex
Pre-revenue-scale private company. 1X has not disclosed revenue, margins, burn, or headcount. Economically it is a capital-intensive hardware + embodied-AI R&D bet: it manufactures its own robots, employs a paid workforce of remote teleoperators, and funds a long path to autonomy from venture equity. The reported jump from ~$820M (Jan 2024) to a ~$10B target (Sept 2025) is a ~12x mark driven by the NEO consumer launch narrative and a sector-wide re-rating, not by disclosed financial results.
Revenue trend
Margins
unknown
unknown
COGS structure
Not disclosed. Structurally: robot BOM (tendon-driven actuators, dual 8MP fisheye cameras, on-board compute, batteries, structure), owned-factory labor and overhead, plus the ongoing labor cost of human teleoperators servicing deployed units — a variable cost that scales with the fleet until autonomy improves.
Capex
Not quantified. Two owned manufacturing sites (Hayward, California; Moss, Norway) imply meaningful and rising capex to scale NEO production for 2026 deliveries and the EQT industrial channel.
Latest earnings
n/a
No financial guidance. Operational guidance: NEO deliveries begin 2026 (US first); EQT partnership targets up to 10,000 units by 2030.
- NEO price (one-time)
- $20,000
- NEO subscription
- $499/month (includes required services)
- Pre-order deposit / reservations
- $200 refundable; 10,000+ reservations reported
- Initial autonomy (company claim)
- ~60-70% of tasks; remainder via remote Expert Mode teleoperation
- Reported target valuation
- ~$10B (Series C in progress, not confirmed closed)
- Last confirmed valuation
- ~$820M post (Series B, Jan 2024)
Growth drivers
- NEO consumer launch — $20k unit or $499/mo subscription, deliveries primarily in the US in 2026, other markets from 2027
- EQT industrial channel — partnership (Dec 2025) to make up to 10,000 NEO units available across EQT's 300+ portfolio companies (manufacturing / warehousing / logistics) 2026-2030, with US pilots first
- Teleoperation-to-autonomy data flywheel raising the autonomous share of tasks over time (company cites ~60-70% autonomy initially, remainder via Expert Mode)
- OpenAI relationship as an AI / foundation-model and credibility tailwind
- Sector capital inflow — humanoid-robotics re-rating in 2025-2026
Bull & bear
1X is the leading name specifically targeting the home, with a shipping-soon product, elite backers, and a data-flywheel path from teleoperation to autonomy in the largest addressable labor market on earth.
- Home is the biggest and least-served humanoid market; 1X has a real consumer SKU, a price, 10,000+ reservations, and a 2026 delivery date while most rivals chase factories
- The teleop-first model is a pragmatic bootstrap: collect real household data now, ride model improvements to raise autonomy and collapse the labor cost later
- OpenAI + EQT backing gives both AI credibility and a large industrial demand channel (up to 10,000 units across 300+ portfolio companies) that funds the ramp
- Reported ~$10B target implies investor conviction that 1X can be a category winner; a ~12x step-up in ~18 months signals strong momentum
- Soft, human-safe, tendon-driven design is a genuine differentiator for the in-home use case versus heavy industrial competitors
Today NEO is a $20k tele-operated appliance that can put remote operators' eyes inside your home; the AI autonomy that justifies a $10B mark is not here, and 1X is out-gunned on capital by Figure and Tesla and undercut on price/volume by Unitree.
- The product is human-piloted, not autonomous — complex Oct 2025 demos required a remote VR operator; early buyers are effectively paying to be beta testers and data labelers
- In-home teleoperation is a structural privacy and security liability that could cap consumer adoption regardless of stated scheduling/permission safeguards
- No disclosed revenue or margins, while teleop labor is a per-unit variable cost that grows with the fleet — the opposite of software operating leverage until autonomy lands
- Competitive gap: Figure is reportedly ~$39B post-money, Tesla self-funds Optimus at auto scale, and Unitree shipped 5,500+ units in 2025 at ~$16k — 1X must win on a much thinner balance sheet
- A ~$10B target is ~12x the last confirmed ($820M) valuation on unproven demand and unproven autonomy — real down-round risk if the round doesn't close on those terms or the sector re-rates
What it is worth
Private venture mark / comparable-round triangulation (no public price, no exchange listing, no disclosed financials).
Round closes below target, or a later down-round, if autonomy lags, privacy backlash caps consumer demand, or the sector de-rates — the ~12x mark is the most fragile part of the story and could revert toward the low single-digit billions.
~$10B target round closes near terms but the mark stays autonomy-dependent; value hinges on execution over the next 12-24 months as teleop-to-autonomy is proven or not.
~$10B+ close (or higher) holds and re-rates further if NEO reservations convert to paid deliveries, autonomy visibly improves, and the EQT industrial channel scales — putting 1X among the humanoid category leaders.
Last CONFIRMED priced round: Series B ~$820M post (Jan 2024, EQT Ventures-led, ~$100M). Reported Series C targets up to ~$1B at ~$10B (Sept 2025, The Information) — a ~12x step-up on the NEO consumer launch and sector re-rating, NOT yet confirmed closed at those terms. Peer set: Figure ~$39B (Sept 2025), Apptronik ~$5.3B (Feb 2026), Unitree low-cost/high-volume (Shanghai IPO filed). With no disclosed revenue, the mark is narrative- and comp-driven, not fundamentals-supported. Not financial advice.
SWOT
Strengths
- First-mover claim on a consumer-ready home humanoid with an actual price, open pre-orders (10,000+ reservations), and a 2026 delivery date — ahead of most rivals on the home form factor
- Marquee backers: OpenAI Startup Fund, EQT Ventures, Tiger Global, Samsung NEXT — capital and AI credibility
- Owned manufacturing in two geographies (Hayward CA + Moss Norway) rather than pure outsourcing
- Soft, lightweight, tendon-driven design positioned as safer around people in the home than heavy industrial humanoids
- Dual go-to-market: consumer home plus an industrial channel underpinned by EQT's 300+ portfolio companies
Weaknesses
- Core capability is teleoperated, not autonomous — complex chores in the Oct 2025 demos were reportedly 100% human-piloted via VR; the product today ships human labor alongside AI
- Severe privacy exposure — remote human operators can view (dual 8MP cameras) and control inside customers' homes
- No disclosed revenue, margins, or unit economics — teleop labor is a variable cost that scales with the fleet, pressuring gross margin until autonomy improves
- Unproven that $20k / $499-mo consumer demand exists at volume for a beta-grade product (reservations are refundable deposits, not paid deliveries)
- Capital-intensive hardware + manufacturing with a long, uncertain road to true autonomy
Opportunities
- If autonomy genuinely climbs, teleop cost falls out and margins/scalability transform — the entire thesis
- Large TAM narrative for household + light-industrial labor automation
- Enterprise/industrial deployment (EQT channel) can generate recurring revenue and real-world data faster than the home
- Deep OpenAI relationship could yield differentiated foundation-model / VLA capability
- Aging-population / labor-shortage demographics support long-run demand for physical automation
Threats
- Better-capitalized rivals — Tesla Optimus (in-house at auto scale, though no commercial sales yet), Figure AI (~$39B post-money, Sept 2025), Apptronik (~$5.3B, Feb 2026), Agility Robotics, plus low-cost Unitree (~$16k base G1, 5,500+ units shipped in 2025)
- Regulatory / consumer backlash on in-home surveillance and teleop data collection could throttle the consumer channel
- Safety incident risk — a humanoid operating in homes carries physical-harm and liability tail risk
- Autonomy may progress slower than promised, stranding the teleop cost structure and the valuation
- Sector is a hype-bubble candidate; a funding-winter re-rating would hit a company raising into a ~12x mark-up
Moats, dependencies & bottlenecks
Moats
low-to-moderate Being first to a priced consumer home humanoid earns mindshare, but no structural lock-in; rivals can and are following.
Real in-home interaction data is scarce and valuable IF it compounds into autonomy faster than rivals — the whole moat hinges on this actually working.
Capital, AI access, and a large industrial demand channel; partnership-based, not owned or exclusive.
Custom actuator / soft-robot engineering is hard to copy quickly; capital-intensive to sustain.
Dependencies
Investor / AI-model relationship Credibility and potential model edge; OpenAI also backs rival Figure, so the relationship is not exclusive.
Investor + primary industrial channel Up-to-10,000-unit partnership concentrates near-term B2B demand in one sponsor's ecosystem; each portfolio company still signs individually.
Training and on-robot inference depend on scarce accelerators; sector-wide, not 1X-specific.
Product function currently depends on a scalable, trustworthy, background-checked human operator pool — a cost and a privacy/liability surface.
Pre-revenue-scale and capital-intensive; needs the in-progress ~$1B round (and more) to reach autonomy and volume.
Advantages
- Near-shipping consumer product with a concrete price, 10,000+ reservations, and a 2026 delivery date
- Home-first positioning and human-safe soft (tendon-drive) design
- Top-tier investor syndicate (OpenAI, EQT, Tiger Global, Samsung NEXT)
- Dual consumer + industrial go-to-market with a large EQT demand channel
- Vertically integrated hardware and two-geography manufacturing
Weaknesses
- Autonomy is aspirational; product is teleoperated today
- Privacy/security exposure inherent to in-home remote operation
- No disclosed financials; teleop labor pressures unit economics
- Out-capitalized by Figure and Tesla; undercut on price/volume by Unitree
- Valuation step-up outruns demonstrated fundamentals
Bottlenecks
- True autonomy — the gap between ~60-70% claimed and 100% is where the economics live, and closing it is unproven
- Teleop labor cost that scales roughly with deployed units
- Manufacturing yield and cost to produce a $20k robot at volume with acceptable margin
- Consumer trust on in-home cameras / remote control
- Capital intensity versus larger-balance-sheet rivals
Top signals & trends
Top signals
Investor conviction — but a target, not a confirmed close; watch for the final terms.
Commercialization milestone; conversion of refundable reservations to paid deliveries is the real test.
Real B2B demand, though concentrated in one sponsor's ecosystem and per-company opt-in.
Undercuts the autonomy narrative that the valuation rests on.
Consumer-adoption and regulatory risk to the home channel.
Trends
Figure ~$39B, Apptronik ~$5.3B, Tesla Optimus ramp — sector re-rating lifts 1X but also its competition.
Validates 1X's pragmatic model but exposes that no one has full home autonomy yet.
Price and volume pressure on any consumer-priced humanoid.
Long-run demand tailwind for physical-labor automation.
Regulatory and reputational risk specific to 1X's teleop model.
Ecosystem & competitor graph
Suppliers feed the company; customers pull from it. Line thickness shows the strength of each tie (supply-chain dependency, customer earnings contribution). Hover to isolate a tie.
GPUs/accelerators and robotics compute (Jetson/Isaac) for training and on-robot inference; sector-wide enabler.
Not publicly disclosed; 1X designs its own tendon-drive actuators in-house.
$20k / $499-mo NEO buyers; deliveries begin in the US in 2026, other markets from 2027.
300+ industrial / logistics / manufacturing firms; up to 10,000 units 2026-2030 under the Dec 2025 partnership.
In-house humanoid self-funded at auto-manufacturing scale; best-capitalized threat, but made no commercial sales through 2025 (~150-1,000 internal units), has repeatedly missed Optimus targets, and third-party sales are not expected before 2027.
US humanoid startup, reportedly ~$39B post-money (Series C, Sept 2025); BMW line pilot; private.
US industrial humanoid, ~$5.3B post-money (Series A reopened, Feb 2026); Mercedes-Benz and GXO pilots; private.
US warehouse-focused humanoid, commercially deployed (GXO); private.
Owned by Hyundai Motor Group (KRX: 005380; US OTC: HYMTF); electric Atlas; industrial focus.
China-based; shipped 5,500+ units in 2025, ~$16k base G1, high volume; filed for a Shanghai IPO. Named for competitive/pricing context only — not a buy/own call.
Canadian dexterous-manipulation humanoid; private.